Medpace Holdings Statistics
Total Valuation
MEDP has a market cap or net worth of $13.78 billion. The enterprise value is $13.89 billion.
| Market Cap | 13.78B |
| Enterprise Value | 13.89B |
Important Dates
The next estimated earnings date is Monday, October 20, 2025, after market close.
| Earnings Date | Oct 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MEDP has 28.09 million shares outstanding. The number of shares has decreased by -2.69% in one year.
| Current Share Class | 28.09M |
| Shares Outstanding | 28.09M |
| Shares Change (YoY) | -2.69% |
| Shares Change (QoQ) | -6.58% |
| Owned by Insiders (%) | 20.68% |
| Owned by Institutions (%) | 95.06% |
| Float | 22.26M |
Valuation Ratios
The trailing PE ratio is 36.46 and the forward PE ratio is 33.00. MEDP's PEG ratio is 2.91.
| PE Ratio | 36.46 |
| Forward PE | 33.00 |
| PS Ratio | 6.65 |
| Forward PS | 5.15 |
| PB Ratio | 79.76 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 23.77 |
| P/OCF Ratio | 22.45 |
| PEG Ratio | 2.91 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.42, with an EV/FCF ratio of 23.95.
| EV / Earnings | 33.20 |
| EV / Sales | 6.22 |
| EV / EBITDA | 27.42 |
| EV / EBIT | 29.08 |
| EV / FCF | 23.95 |
Financial Position
The company has a current ratio of 0.43, with a Debt / Equity ratio of 0.87.
| Current Ratio | 0.43 |
| Quick Ratio | 0.35 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | 0.27 |
| Debt / FCF | 0.26 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 89.38% and return on invested capital (ROIC) is 48.16%.
| Return on Equity (ROE) | 89.38% |
| Return on Assets (ROA) | 17.09% |
| Return on Invested Capital (ROIC) | 48.16% |
| Return on Capital Employed (ROCE) | 135.95% |
| Revenue Per Employee | $378,269 |
| Profits Per Employee | $70,898 |
| Employee Count | 5,900 |
| Asset Turnover | 1.28 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MEDP has paid $77.07 million in taxes.
| Income Tax | 77.07M |
| Effective Tax Rate | 15.56% |
Stock Price Statistics
The stock price has increased by +46.65% in the last 52 weeks. The beta is 1.44, so MEDP's price volatility has been higher than the market average.
| Beta (5Y) | 1.44 |
| 52-Week Price Change | +46.65% |
| 50-Day Moving Average | 426.38 |
| 200-Day Moving Average | 348.18 |
| Relative Strength Index (RSI) | 63.99 |
| Average Volume (20 Days) | 321,899 |
Short Selling Information
The latest short interest is 2.25 million, so 8.02% of the outstanding shares have been sold short.
| Short Interest | 2.25M |
| Short Previous Month | 2.28M |
| Short % of Shares Out | 8.02% |
| Short % of Float | 10.13% |
| Short Ratio (days to cover) | 6.08 |
Income Statement
In the last 12 months, MEDP had revenue of $2.23 billion and earned $418.30 million in profits. Earnings per share was $13.46.
| Revenue | 2.23B |
| Gross Profit | 1.53B |
| Operating Income | 477.51M |
| Pretax Income | 397.17M |
| Net Income | 418.30M |
| EBITDA | 506.48M |
| EBIT | 477.51M |
| Earnings Per Share (EPS) | $13.46 |
Balance Sheet
The company has $46.33 million in cash and $149.83 million in debt, giving a net cash position of -$103.50 million or -$3.68 per share.
| Cash & Cash Equivalents | 46.33M |
| Total Debt | 149.83M |
| Net Cash | -103.50M |
| Net Cash Per Share | -$3.68 |
| Equity (Book Value) | 172.35M |
| Book Value Per Share | 6.15 |
| Working Capital | -699.64M |
Cash Flow
In the last 12 months, operating cash flow was $614.10 million and capital expenditures -$34.29 million, giving a free cash flow of $579.82 million.
| Operating Cash Flow | 614.10M |
| Capital Expenditures | -34.29M |
| Free Cash Flow | 579.82M |
| FCF Per Share | $20.64 |
Margins
Gross margin is 68.51%, with operating and profit margins of 21.40% and 18.74%.
| Gross Margin | 68.51% |
| Operating Margin | 21.40% |
| Pretax Margin | 22.20% |
| Profit Margin | 18.74% |
| EBITDA Margin | 22.69% |
| EBIT Margin | 21.40% |
| FCF Margin | 25.98% |
Dividends & Yields
MEDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.69% |
| Shareholder Yield | 2.69% |
| Earnings Yield | 3.03% |
| FCF Yield | 4.21% |
Analyst Forecast
The average price target for MEDP is $424.10, which is -13.56% lower than the current price. The consensus rating is "Hold".
| Price Target | $424.10 |
| Price Target Difference | -13.56% |
| Analyst Consensus | Hold |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 11.61% |
| EPS Growth Forecast (5Y) | 10.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MEDP has an Altman Z-Score of 5.7 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.7 |
| Piotroski F-Score | 6 |